Peak flow as a predictor of cause-specific mortality in china: Results from a 15-year prospective study of 170 000 men

International Journal of Epidemiology

Volumn 42, Issue 3, 2013, Pages 803-815

  Smith, Margaret ^a   Zhou, Maigeng ^b   Wang, Lijun ^b   Peto, Richard ^a   Yang, Gonghuan ^b   Chen, Zhengming ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Cardiovascular disease; China; COPD; Lung cancer; Mortality; Peak expiratory flow rate; Prospective studies; Respiratorytract disease

Indexed keywords

CANCER; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; DEVELOPING WORLD; PEAK FLOW; RESPIRATORY DISEASE; SMOKING;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CHINA; COHORT ANALYSIS; CORRELATION ANALYSIS; FOLLOW UP; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MORTALITY; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY TRACT DISEASE;

CARDIOVASCULAR DISEASE; CHINA; COPD; LUNG CANCER; MORTALITY; PEAK EXPIRATORY FLOW RATE; PROSPECTIVE STUDIES; RESPIRATORY-TRACT DISEASE;

ADULT; AGED; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CHINA; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MORTALITY; NEOPLASMS; PEAK EXPIRATORY FLOW RATE; POPULATION SURVEILLANCE; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RESPIRATORY TRACT DISEASES; RISK FACTORS; SMOKING; TIME FACTORS;

CHINA;

EID: 84881563759     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyt079     Document Type: Article

References (36)

1. Hole DJ, Watt GC, Davey Smith G, Hart CL, Gillis CR, Hawthorne VM. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 1996;313: 711-15.
2. Knuiman MW, James AL, Divitini ML, Ryan G, Bartholomew HC, Musk AW. Lung function, respiratory symptoms, and mortality: results from the Busselton Health Study. Ann Epidemiol 1999;9:297-306.
3. Schunemann HJ, Dorn J, Grant BJ, Winkelstein W Jr, Trevisan M. Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest 2000;118: 656-64.
4. Mannino DM, Buist AS, Petty TL, Enright PL, Redd SC. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax 2003;58:388-93.
5. Stavem K, Aaser E, Sandvik L et al. Lung function, smoking and mortality in a 26-year follow-up of healthy middle-aged males. Eur Respir J 2005;25:618-25.
6. Mannino DM, Aguayo SM, Petty TL, Redd SC. Low lung function and incident lung cancer in the United States: data From the First National Health and Nutrition Examination Survey follow-up. Arch Intern Med 2003; 163:1475-80.
7. Purdue MP, Gold L, Jarvholm B, Alavanja MC, Ward MH, Vermeulen R. Impaired lung function and lung cancer incidence in a cohort of Swedish construction workers. Thorax 2007;62:51-56.
8. Wasswa-Kintu S, Gan WQ, Man SF, Pare PD, Sin DD. Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis. Thorax 2005;60:570-75.
9. Ferrie JE, Singh-Manoux A, Kivimaki M et al. Cardiorespiratory risk factors as predictors of 40-year mortality in women and men. Heart 2009;95:1250-57.
10. Sin DD, Wu L, Man SF. The relationship between reduced lung function and cardiovascular mortality: a populationbased study and a systematic review of the literature. Chest 2005;127:1952-59.
11. Gulsvik AK, Gulsvik A, Skovlund E et al. The association between lung function and fatal stroke in a community followed for 4 decades. J Epidemiol Community Health 2012;66:1030-36.
12. Truelsen T, Prescott E, Lange P, Schnohr P, Boysen G. Lung function and risk of fatal and non-fatal stroke. The Copenhagen City Heart Study. Int J Epidemiol 2001; 30:145-51.
13. Fragoso CA, Gahbauer EA, Van Ness PH, Concato J, Gill TM. Peak expiratory flow as a predictor of subsequent disability and death in community-living older persons. J Am Geriatr Soc 2008;56:1014-20.
14. Roberts MH, Mapel DW. Limited lung function: impact of reduced peak expiratory flow on health status, healthcare utilization, and expected survival in older adults. Am J Epidemiol 2012;176:127-34.
15. Cook NR, Evans DA, Scherr PA, Speizer FE, Taylor JO, Hennekens CH. Peak expiratory flow rate and 5-year mortality in an elderly population. Am J Epidemiol 1991; 133:784-94.
16. Hansen EF, Vestbo J, Phanareth K, Kok-Jensen A, Dirksen A. Peak flow as predictor of overall mortality in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163:690-93.
17. Simons LA, McCallum J, Friedlander Y, Simons J. Risk factors for ischemic stroke: Dubbo Study of the elderly. Stroke 1998;29:1341-46.
18. Simons LA, McCallum J, Simons J, Friedlander Y. Relationship of peak expiratory flow rate with mortality and ischaemic heart disease in elderly Australians. Med J Aust 1997;166:526-29.
19. Jain P, Kavuru MS, Emerman CL, Ahmad M. Utility of peak expiratory flow monitoring. Chest 1998;114:861-76.
20. Bellia V, Pistelli F, Giannini D et al. Questionnaires, spirometry and PEF monitoring in epidemiological studies on elderly respiratory patients. Eur Respir J Suppl 2003;40:s21-s27.
21. Aggarwal AN, Gupta D, Jindal SK. The relationship between FEV1 and peak expiratory flow in patients with airways obstruction is poor. Chest 2006;130:1454-61.
22. Hebert JR, Pednekar MS, Gupta PC. Forced expiratory volume predicts all-cause and cancer mortality in Mumbai, India: results from a population-based cohort study. Int J Epidemiol 2010;39:1619-27.
23. Fang X, Wang X, Bai C. COPD in China: the burden and importance of proper management. Chest 2011;139: 920-29.
24. Zhong N, Wang C, Yao W et al. Prevalence of chronic obstructive pulmonary disease in China: a large, populationbased survey. Am J Respir Crit Care Med 2007;176:753-60.
25. Zhou Y, Wang C, Yao W et al. COPD in Chinese nonsmokers. Eur Respir J 2009;33:509-18.
26. Niu SR, Yang GH, Chen ZM et al. Emerging tobacco hazards in China: 2. Early mortality results from a prospective study. BMJ 1998;317:1423-24.
27. Liu BQ, Peto R, Chen ZM et al. Emerging tobacco hazards in China: 1. Retrospective proportional mortality study of one million deaths. BMJ 1998;317:1411-22.
28. Cole TJ. The influence of height on the decline in ventilatory function. Int J Epidemiol 1974;3:145-52.
29. Plummer M. Improved estimates of floating absolute risk. Stat Med 2004;23:93-104.
30. Easton DF, Peto J, Babiker AG. Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. Stat Med 1991;10:1025-35.
31. Ebi-Kryston KL. Respiratory symptoms and pulmonary function as predictors of 10-year mortality from respiratory disease, cardiovascular disease, and all causes in the Whitehall Study. J Clin Epidemiol 1988;41:251-60.
32. Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: Role of comorbidities. Eur Respir J 2006;28: 1245-57.
33. Cook NR, Albert MS, Berkman LF, Blazer D, Taylor JO, Hennekens CH. Interrelationships of peak expiratory flow rate with physical and cognitive function in the elderly: MacArthur Foundation studies of aging. J Gerontol A Biol Sci Med Sci 1995;50:M317-23.
34. Singh-Manoux A, Dugravot A, Kauffmann F et al. Association of lung function with physical, mental and cognitive function in early old age. Age (Dordr) 2011;33: 385-92.
35. Nelson SB, LaVange LM, Nie Y et al. Questionnaires and pocket spirometers provide an alternative approach for COPD screening in the general population. Chest 2012; 142:358-66.
36. Tian J, Zhou Y, Cui J et al. Peak expiratory flow as a screening tool to detect airflow obstruction in a primary health care setting. Int J Tuberc Lung Dis 2012;16: 674-80